factors showed no competition for binding to these receptors. WEHI-3B (D-), a subline of WEHI-3B that cannot be induced to differentiate by G-CSF, showed no specific binding of this factor, indicating that it is deficient in receptor presentation.
Colony-stimulating factors are a family of hemopoietic regulatory growth factors required for the survival, proliferation, and differentiation in vitro of hemopoietic progenitor cells (1) . The same factors also stimulate metabolic and functional activities of postmitotic mature hemopoietic cells (2) (3) (4) (5) . Four types of colony-stimulating factor have been purified from murine tissue sources and can be distinguished by unique molecular and biological properties (6) . M-CSF stimulates nearly exclusively macrophage colonies to develop from bone marrow precursor cells (7) ; GM-CSF stimulates neutrophilic granulocyte and macrophage colonies (8) ; Multi-CSF [also known as burst-promoting activity (9) , interleukin 3 (10), P-cell stimulating factor (11) , mast cell growth factor (12) , and hemopoietic cell growth factor (13) ] stimulates neutrophilic and eosinophilic granulocyte, macrophage, erythroid, megakaryocyte, and mast cell colonies; and G-CSF stimulates predominantly neutrophilic granulocyte colonies (14, 15) .
Recently, there has been interest in the possibility of using normal hemopoietic growth factors to suppress myeloid leukemias by inducing terminal differentiation in the leukemic cells (16) (17) (18) (19) . The purification to homogeneity of the factor in mouse-lung-conditioned medium able to induce differentiation in the murine myelomonocytic leukemic cell line WEHI-3B (D+) (14) indicated that it was separable from GM-CSF and was identical to G-CSF (14) . Purified G-CSF induced the production of differentiated cells from, and suppressed the self-renewal capacity of, WEHI-3B (D+) leukemic stem cells (20) while GM-CSF had weak differentiationinducing activity and M-CSF and Multi-CSF had none. On the other hand, G-CSF had no detectable effects on a differentiation-unresponsive subline of WEHI-3B (D-) (20) .
To understand better the specificity and action of G-CSF on normal and leukemic cells we have radioiodinated purified G-CSF and measured its binding to normal hemopoietic cells and various leukemic cell lines.
MATERIALS AND METHODS
Cells and Cell Lines. Differentiation-responsive (D+) and unresponsive (D-) sublines of the BALB/c murine myelomonocytic leukemia WEHI-3B were maintained as described (20) . Other tumor cell lines were kindly supplied by A. W. Harris of this institute and were harvested during the exponential growth phase. All normal murine cells used in this study were obtained from C57BL/6f/J/WEHI mice (3-4 months old, either sex).
Colony-Stimulating Factors. GM-CSF and M-CSF were purified to homogeneity by modifications of reported techniques (8, 21) and were gifts from A. W. Burgess. Multi-CSF purified to homogeneity from pokeweed mitogen-stimulated murine spleen cell conditioned medium and Multi-CSF highly purified (>100,000-fold) from WEHI-3B (D-) conditioned medium were gifts from R. L. Cutler.
Preparation of Iodinated G-CSF. G-CSF was purified from mouse-lung-conditioned medium as described (14) and consisted of one major silver-stained band migrating with an apparent Mr of 25,000 on NaDodSO4/polyacrylamide gels.
Amounts of 1 ,ug or less were iodinated in 150 ,tl by using a two-phase method described by Tejedor and Ballesta (22) except that 12 ,ul of 0.125 mM KI was added with 10 ,ul of carrier-free Na1251 (1 mCi; 1 Ci = 37 GBq) and the filter paper was changed three times over a 40-min incubation period at room temperature. Reactants were separated from labeled G-CSF by passage of the reaction mixture through a small column of Sephadex G-25 medium (Pharmacia, Uppsala, Sweden) (14) . The specific radioactivity of 1251-G-CSF preparations was determined by self-displacement analysis as described (23) The tubes were centrifuged at 340 x g for 5 min and then cut with a scalpel blade 2-3 mm above the cell pellet. The radioactivities of pellet and supernatant were measured separately in a Packard Autogamma 500 C instrument at a counting efficiency of 75% for 1 min or longer if required to reduce the standard deviation to less than 2%. Nonspecific binding, as measured in the presence of (usually) a 20-fold excess of pure unlabeled G-CSF, increased linearly with amount of 125I-G-CSF added and was typically 1-2% of added radioactive factor. For analysis of binding data by the method of Scatchard, the radioactivity associated with unbound (free) 125I-G-CSF was measured directly and corrected for the maximal binding capacity of the preparation.
RESULTS
Radioiodination of G-CSF. Repeated attempts to obtain biologically active preparations of iodinated G-CSF by using chloramine-T or IODO-GEN were unsuccessful. However, as shown in Fig. 1A , microgram or submicrogram amounts of pure G-CSF could be iodinated to high specific radioactivity with no detectable loss of colony-stimulating activity for normal cells or differentiation-inducing activity for WEHI-3B (D+) leukemic cells when the two-phase radioiodination method (22) was used. The figure also shows that, with the inclusion of Tween 20 in all buffers, quantitative recovery of iodinated G-CSF was obtained without the use of protein carrier (14) . lodinated G-CSF could be stored carrier-free at -20°C for at least 1 month with no loss of specific cell-binding capacity.
The total specific binding capacity of 1251I-G-CSF (purified through Sephadex G-25 medium and CM-Sepharose CL-6B chromatography) was measured in sequential binding experiments with WEHI-3B (D+) cells, and the results indicated that 70% of the total radioactivity was associated with molecules able to specifically bind to WEHI-3B (D+) cells (Fig.  1B) . Material of this type was used in all subsequent experiments.
The specific radioactivity of 125I-G-CSF preparations was determined by self-displacement analysis of the binding of 1251I-G-CSF to WEHI-3B (D+) cells by increasing concentrations of 125I-G-CSF or unlabeled pure G-CSF. The approximate parallelism of these curves (Fig. 1C) indicated that there was no marked difference in binding affinity for WEHI-3B (D+) cells between 125I-G-CSF and unlabeled G-CSF. The calculated specific radioactivity of 125I-G-CSF preparations was between 240,000 and 450,000 cpm/ng.
Binding Characteristics of 125I-G-CSF to WEHI-3B (D+)
Cells. The amount of 125I-G-CSF specifically bound to WEHI-3B (D+) leukemic cells or normal murine (C57BL) bone marrow cells was linear with cell number and extrapolated through the origin ( Fig. 2A) .
Specific binding of 125I-G-CSF to WEHI-3B (D+) cells showed different kinetics and levels of saturable binding at different temperatures (Fig. 2B) . The binding at 370C was relatively rapid (complete within 1 hr) and achieved a steadystate level over a 5-hr period. Binding was slower at 230C, The binding to J774 was saturable and reversible with an affinity and receptor number similar to that for WEHI-3B (D+) cells (data not shown), and this line also possesses M-CSFspecific receptors (21) . This may reflect the common cellular origin of granulocytes and macrophages and the ability of G-CSF to stimulate a subset of such precursor cells (15) . 1251_ G-CSF also showed specific binding to normal murine bone marrow cells but not to spleen and thymus cells (Table 1) . In other experiments, at higher cell concentrations, thymocytes remained negative but spleen cells showed low but significant binding of 125I-G-CSF. Autoradiographic analysis indicated that, for both spleen and bone marrow, binding was restricted predominantly to granulocytic cells. The ability of unlabeled G-CSF and other functionally related purified colony-stimulating factors to compete with 125I-G-CSF for binding sites on WEHI-3B (D+) cells is shown in Fig. 3 . Unlabeled G-CSF was able to compete in a concentration-dependent manner for 80-90% of the radioactivity bound to WEHI-3B (D+) cells. No significant competition was seen with any other colony-stimulating factor over a comparable concentration range. In other experiments, insulin (1 unit/ml), glucagon (10 ,AM), multiplication-stimulating activity (0.22 ug/ml), somatostatin (10 ,uM), epidermal growth factor (6 ,ug/ml), nerve growth factor (12 ,g/ml), and fibroblast growth factor (0.22 ,g/ml) failed to modify (within + 10%) the binding of 125I-G-CSF to WEHI-3B (D+) cells under conditions in which unlabeled G-CSF inhibited total binding by 80%. Colony-stimulating factor, units/ml associated with dead cells and debris, in contrast to the clear labeling of intact D+ cells (Fig. 5) . Analysis of the binding data by the method of Scatchard (25) showed that the binding of 125I-G-CSF to WEHI-3B (D+) cells was bimodal, the negative inverse of the linear portion giving a dissociation constant of 94 pM, with the intercept on the abscissa yielding a value of 350 sites per cell (Fig. 4B) .
In three other experiments the dissociation constant varied between 60 and 110 pM and the average number of binding sites per cell between 300 and 700. Since similar results were obtained in serum-free medium and since under these conditions WEHI-3B (D+) cells did not secrete detectable levels of G-CSF, this low number of receptors was probably not due to occupation of receptors prior to the experiment. The nonlinearity at low concentrations of bound 125I-G-CSF (Fig. 4B) (15) .
The lack of cross-reactivity of any of the colony-stimulating factors with the G-CSF receptor on WEHI-3B (D+) cells was also surprising since each of these factors (with the exception of M-CSF) can also stimulate granulocyte colony formation, and they appear to be functionally related. On the other hand, M-CSF and Multi-CSF have no detectable activity on WEHI-3B (D+) cells, while GM-CSF has only weak differentiation-inducing activity (15) . Moreover, G-CSF, GM-CSF, and Multi-CSF have been shown not to cross-react with the M-CSF receptor on macrophages (26), although both GM-CSF and Multi-CSF can stimulate macrophage colony formation (6) . This suggests that certain hemopoietic cells simultaneously express separate receptors for several colony-stimulating factors.
The most striking observation in the present study was the absence of specific binding activity for I251-G-CSF from the differentiation-unresponsive subline WEHI-3B (D- 
